129 related articles for article (PubMed ID: 35278672)
21. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
[TBL] [Abstract][Full Text] [Related]
22. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
23. Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
Peters M; van der Voort van Zyp JRN; Moerland MA; Hoekstra CJ; van de Pol S; Westendorp H; Maenhout M; Kattevilder R; Verkooijen HM; van Rossum PSN; Ahmed HU; Shah TT; Emberton M; van Vulpen M
Brachytherapy; 2016; 15(3):296-305. PubMed ID: 26948662
[TBL] [Abstract][Full Text] [Related]
24. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.
Chen CP; Weinberg V; Shinohara K; Roach M; Nash M; Gottschalk A; Chang AJ; Hsu IC
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):324-9. PubMed ID: 23474112
[TBL] [Abstract][Full Text] [Related]
25. [The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children].
Haie-Meder C; Flamant F; Revillon Y; Valayer J; Gruner M; Martelli H; Habrand JL; Terrier-Lacombe MJ; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):302-5. PubMed ID: 7893115
[TBL] [Abstract][Full Text] [Related]
26. Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy.
Sasaki H; Kido M; Miki K; Kuruma H; Takahashi H; Aoki M; Egawa S
Int J Urol; 2014 Jun; 21(6):572-7. PubMed ID: 24372730
[TBL] [Abstract][Full Text] [Related]
27. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation.
Wong WW; Buskirk SJ; Schild SE; Prussak KA; Davis BJ
J Urol; 2006 Nov; 176(5):2020-4. PubMed ID: 17070243
[TBL] [Abstract][Full Text] [Related]
28. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
[TBL] [Abstract][Full Text] [Related]
29. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas.
Nag S; Tippin D; Ruymann FB
J Pediatr Hematol Oncol; 2003 Jun; 25(6):448-52. PubMed ID: 12794522
[TBL] [Abstract][Full Text] [Related]
30. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
31. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
[TBL] [Abstract][Full Text] [Related]
32. MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study.
Peters M; van Son MJ; Moerland MA; Kerkmeijer LGW; Eppinga WSC; Meijer RP; Lagendijk JJW; Shah TT; Ahmed HU; van der Voort van Zijp JRN
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1045-1053. PubMed ID: 30926575
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
34. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.
Yamada Y; Kollmeier MA; Pei X; Kan CC; Cohen GN; Donat SM; Cox BW; Zelefsky MJ
Brachytherapy; 2014; 13(2):111-6. PubMed ID: 24373762
[TBL] [Abstract][Full Text] [Related]
35. Conservative treatment for lower gynecological tract malignancies in children and adolescents: the Institut Gustave-Roussy experience.
Gerbaulet AP; Esche BA; Haie CM; Castaigne D; Flamant F; Chassagne D
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):655-8. PubMed ID: 2777654
[TBL] [Abstract][Full Text] [Related]
36. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
37. Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].
Aluwini S; van Rooij PH; Kirkels WJ; Boormans JL; Kolkman-Deurloo IK; Wijnmaalen A
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):611-7. PubMed ID: 24411629
[TBL] [Abstract][Full Text] [Related]
38. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Biagioli MC
Brachytherapy; 2014; 13(2):123-7. PubMed ID: 24269146
[TBL] [Abstract][Full Text] [Related]
39. Use of an intravaginal spacer in young girls treated with brachytherapy for bladder neck rhabdomyosarcoma: Dosimetric impact for organs at risk sparing and acute tolerance.
Limkin EJ; Guérin F; Espenel S; Terlizzi M; Martelli H; Haie-Meder C; Minard V; Chargari C
Cancer Radiother; 2022 May; 26(3):486-490. PubMed ID: 34711484
[TBL] [Abstract][Full Text] [Related]
40. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
